Where can I learn more about this study?
You can find more information about this study on the websites listed below.
X www.clinicaltrials.gov Once you are on the website, type “NCT02579226”
into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com Once you are on the website, type “D6130C00001”
into the search box, and click “Find a Study”.
Full Study Title: A Phase I, Open-Label, Multicentre Dose Escalation Study to Assess the Safety,
Tolerability, and Pharmacokinetics of AZD2811 in Patients with Advanced Solid Tumours
AstraZeneca Protocol Number: D6130C00001
National Clinical Trials Number: NCT02579226
AstraZeneca sponsored this study and has its headquarters at Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants and their families belong to a large community of people who take
part in clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0_2021_09_07
12 | Clinical Study Results